Disc Medicine
IRON | NASDAQ
$76.59
-$3.41 (-4.26%)
At close: Nov 16, 2026, 4:00 PM ET
$76.59
$0.00 (0.00%)
After-hours:
Nov 16, 2026, 7:30 PM ET
Disc Medicine Company Profile
Company profile explainedCompany Profile
Based in Watertown, Massachusetts, Disc Medicine, Inc. operates as a clinical-stage biotechnology company. Its core mission involves the discovery, development, and commercialization of novel therapeutic solutions for individuals suffering from serious hematological diseases. The company is actively constructing a pipeline of drug candidates, designed to address a variety of these conditions by precisely targeting fundamental biological mechanisms related to red blood cell biology, particularly heme biosynthesis and iron homeostasis.
Key Executives
| Name | Position |
|---|---|
| John D. Quisel | Chief Executive Officer, President & Director |
| Jean Franchi | Chief Financial Officer |
| Rahul Khara | Chief Legal Officer & Secretary |
| Brian MacDonald | Founder & Chair of Scientific Advisory Board |
| Donald William Nicholson | Executive Chairman |
| Jonathan Yu | Chief Opearating Officer |
| Lisa Amaya Price | Chief Human Resources Officer |
| Pamela Stephenson | Chief Commercial Officer |
| Rahul Rajan Kaushik | Chief Technical Officer |
| Srikanth Venkatraman | Senior Vice President & Head of Chemistry |
| William Jacob Savage | Chief Medical Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Oct 26, 2026 | SC 13D/A | [Amend] Filing |
| Oct 22, 2026 | 8-K | Current Report |
| Oct 21, 2026 | 4 | Filing |
| Oct 21, 2026 | 424B5 | Filing |
| Oct 20, 2026 | 424B5 | Filing |
| Oct 19, 2026 | 8-K | Current Report |
| Sep 16, 2026 | 4 | Filing |
| Sep 15, 2026 | 4 | Filing |
| Sep 10, 2026 | 8-K | Current Report |
| Sep 09, 2026 | 4 | Filing |
Disc Medicine
| Country | United States |
| IPO Date | Aug 12, 2020 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 165 |
| CEO | John D. Quisel |
Contact Details
321 Arsenal Street Watertown,
Massachusetts 02472 United States
Stock Details
| Ticker Symbol | IRON |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001816736 |
| CUSIP Number | 254604101 |
| ISIN Number | US2546041011 |
| SIC Code | 2834 |
Recent News
- 12 days ago / globenewswire.comDisc Medicine Reports Third Quarter 2026 Financial Results and Provides Business Update
- 15 days ago / globenewswire.comDisc Medicine to Participate in Upcoming Investor Conferences
- 27 days ago / globenewswire.comDisc Medicine Announces Pricing of $450 Million Upsized Public Offering of Common Stock
- 28 days ago / globenewswire.comDisc Medicine Announces Proposed $350 Million Public Offering of Common Stock and Pre-Funded Warrants
- 28 days ago / seekingalpha.comDisc Medicine, Inc. (IRON) Discusses Topline Results of APOLLO Phase III Trial of Bitopertin in EPP Transcript
- 29 days ago / benzinga.comDisc Medicine Delivers Promise For Patients with Sunlight Sensitivity In Successful Pivotal Study
- 29 days ago / invezz.comDisc Medicine stock soars: take profit or buy into strength?
- 29 days ago / gurufocus.comDisc Medicine (IRON) Achieves Positive Phase 3 Trial Results for EPP Treatment
- 29 days ago / marketbeat.comDisc Medicine's Bitopertin Nails Phase III Endpoints, Eyes FDA Resubmission
- 29 days ago / barrons.comDisc Medicine Stock Has Its Best Day Since 2022 as Drug Trial Revives FDA Approval Hopes
Add to Watchlist
Select watchlists to add or remove IRON